跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-RAMIPRIL HCTZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-RAMIPRIL HCTZ
Authorized
STANDARD
TARO-RAMIPRIL HCTZ
sun pharma canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d8c9615894a3df19
Company
sun pharma canada inc
Type
Standard
Approval Details
Approval Id
d8c9615894a3df19
Drug Approval Canada Name
TARO-RAMIPRIL HCTZ
Product Name
TARO-RAMIPRIL HCTZ
Status
Marketed
Status Date
2023-12-12
Original Market Date
2017-12-05
Din
02449463
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09BA05 RAMIPRIL AND DIURETICS
Atc Name
c 09 ba 05
Aig Number
0251649004
Company Name
sun pharma canada inc
Company Address
126 East Drive, Brampton, Ontario, Canada, L6T 1C1
Active Ingredients
HYDROCHLOROTHIAZIDE
25 MG
RAMIPRIL
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d8c9615894a3df19
Type
Standard
Back to Health Canada Approvals